BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 26545871)

  • 1. Toxicity profile and early clinical outcome for advanced head and neck cancer patients treated with simultaneous integrated boost and volumetric modulated arc therapy.
    Franzese C; Fogliata A; Clerici E; Franceschini D; Villa E; D'Agostino G; Navarria P; Mancosu P; Tomatis S; Cozzi L; Scorsetti M
    Radiat Oncol; 2015 Nov; 10():224. PubMed ID: 26545871
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assessing the feasibility of volumetric-modulated arc therapy using simultaneous integrated boost (SIB-VMAT): An analysis for complex head-neck, high-risk prostate and rectal cancer cases.
    Cilla S; Deodato F; Digesù C; Macchia G; Picardi V; Ferro M; Sallustio G; De Spirito M; Piermattei A; Morganti AG
    Med Dosim; 2014; 39(1):108-16. PubMed ID: 24342167
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A comparative analysis between sequential boost and integrated boost intensity-modulated radiation therapy with concurrent chemotherapy for locally-advanced head and neck cancer.
    Vlacich G; Stavas MJ; Pendyala P; Chen SC; Shyr Y; Cmelak AJ
    Radiat Oncol; 2017 Jan; 12(1):13. PubMed ID: 28086954
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Simultaneous integrated boost intensity-modulated radiotherapy for locally advanced head-and-neck squamous cell carcinomas: II--clinical results.
    Lauve A; Morris M; Schmidt-Ullrich R; Wu Q; Mohan R; Abayomi O; Buck D; Holdford D; Dawson K; Dinardo L; Reiter E
    Int J Radiat Oncol Biol Phys; 2004 Oct; 60(2):374-87. PubMed ID: 15380569
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Moderate hypofractionated radiotherapy with volumetric modulated arc therapy and simultaneous integrated boost for pelvic irradiation in prostate cancer.
    Franzese C; Fogliata A; D'Agostino GR; Di Brina L; Comito T; Navarria P; Cozzi L; Scorsetti M
    J Cancer Res Clin Oncol; 2017 Jul; 143(7):1301-1309. PubMed ID: 28271215
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hypofractionation with VMAT versus 3DCRT in post-operative patients with prostate cancer.
    Alongi F; Cozzi L; Fogliata A; Iftode C; Comito T; Clivio A; Villa E; Lobefalo F; Navarria P; Reggiori G; Mancosu P; Clerici E; Tomatis S; Taverna G; Graziotti P; Scorsetti M
    Anticancer Res; 2013 Oct; 33(10):4537-43. PubMed ID: 24123027
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Randomized controlled study comparing simultaneous modulated accelerated radiotherapy versus simultaneous integrated boost intensity modulated radiotherapy in the treatment of locally advanced head and neck cancer.
    Tandon S; Gairola M; Ahlawat P; Rawat S; Aggarwal A; Sharma K; Tiwari S; Karimi AM; Muttagi V; Sachdeva N; Bhushan M
    J Egypt Natl Canc Inst; 2018 Sep; 30(3):107-115. PubMed ID: 29960876
    [TBL] [Abstract][Full Text] [Related]  

  • 8. IMRT using simultaneously integrated boost (SIB) in head and neck cancer patients.
    Studer G; Huguenin PU; Davis JB; Kunz G; Lütolf UM; Glanzmann C
    Radiat Oncol; 2006 Mar; 1():7. PubMed ID: 16722599
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adjuvant volumetric-modulated arc therapy with simultaneous integrated boost in endometrial cancer. Planning and toxicity comparison.
    Macchia G; Cilla S; Morganti AG; Deodato F; Legge F; Piermattei A; Chiantera V; Scambia G; Valentini V; Ferrandina G
    Acta Oncol; 2014 Feb; 53(2):251-8. PubMed ID: 24050516
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of volumetric-modulated arc therapy using simultaneous integrated boosts (SIB-VMAT) of 45 Gy/55 Gy in 25 fractions with conventional radiotherapy in preoperative chemoradiation for rectal cancers: a propensity score case-matched analysis.
    Yamashita H; Ishihara S; Nozawa H; Kawai K; Kiyomatsu T; Okuma K; Abe O; Watanabe T; Nakagawa K
    Radiat Oncol; 2017 Sep; 12(1):156. PubMed ID: 28934968
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Radiotherapy of nasopharyngeal cancer using Rapidarc: dosimetric study of military teaching hospital Mohamed V, Morocco.
    Lalya I; Marnouche EA; Abdelhak M; Zaghba N; Andaloussi K; Elmarjany M; Baddouh L; Dahmani K; Hadadi K; Sifat H; Mansouri H
    BMC Res Notes; 2017 Feb; 10(1):112. PubMed ID: 28241884
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Volumetric modulated arc therapy (VMAT) and simultaneous integrated boost in head-and-neck cancer: is there a place for critical swallowing structures dose sparing?
    Cilla S; Deodato F; Macchia G; Digesù C; Ianiro A; Piermattei A; Valentini V; Morganti AG
    Br J Radiol; 2016; 89(1059):20150764. PubMed ID: 26728543
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Early clinical experience with volumetric modulated arc therapy in head and neck cancer patients.
    Scorsetti M; Fogliata A; Castiglioni S; Bressi C; Bignardi M; Navarria P; Mancosu P; Cozzi L; Pentimalli S; Alongi F; Santoro A
    Radiat Oncol; 2010 Oct; 5():93. PubMed ID: 20950429
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acute toxicities experienced during simultaneous integrated boost intensity-modulated radiotherapy in head and neck cancers--experience from a north Indian regional cancer centre.
    Chakraborty S; Ghoshal S; Patil V; Oinam A; Suresh S
    Clin Oncol (R Coll Radiol); 2009 Nov; 21(9):676-86. PubMed ID: 19748768
    [TBL] [Abstract][Full Text] [Related]  

  • 15. RapidPlan head and neck model: the objectives and possible clinical benefit.
    Fogliata A; Reggiori G; Stravato A; Lobefalo F; Franzese C; Franceschini D; Tomatis S; Mancosu P; Scorsetti M; Cozzi L
    Radiat Oncol; 2017 Apr; 12(1):73. PubMed ID: 28449704
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Volumetric-modulated arc radiotherapy for skull-base and non-skull-base head and neck cancer: a treatment planning comparison with fixed Beam IMRT.
    Chen J; Mok E; Wang L; Chen C; Le QT
    Technol Cancer Res Treat; 2013 Feb; 12(1):11-8. PubMed ID: 22905805
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dosimetric comparison of hybrid volumetric-modulated arc therapy, volumetric-modulated arc therapy, and intensity-modulated radiation therapy for left-sided early breast cancer.
    Lin JF; Yeh DC; Yeh HL; Chang CF; Lin JC
    Med Dosim; 2015; 40(3):262-7. PubMed ID: 26116150
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Three-year outcomes of breast intensity-modulated radiation therapy with simultaneous integrated boost.
    McDonald MW; Godette KD; Whitaker DJ; Davis LW; Johnstone PA
    Int J Radiat Oncol Biol Phys; 2010 Jun; 77(2):523-30. PubMed ID: 19775834
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A dose escalation study with intensity modulated radiation therapy (IMRT) in T2N0, T2N1, T3N0 squamous cell carcinomas (SCC) of the oropharynx, larynx and hypopharynx using a simultaneous integrated boost (SIB) approach.
    Leclerc M; Maingon P; Hamoir M; Dalban C; Calais G; Nuyts S; Serre A; Grégoire V
    Radiother Oncol; 2013 Mar; 106(3):333-40. PubMed ID: 23541643
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ipsilateral kidney sparing in treatment of pancreatic malignancies using volumetric-modulated arc therapy avoidance sectors.
    Chan RW; Podgorsak MB
    Med Dosim; 2015; 40(3):175-80. PubMed ID: 25524821
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.